Cantex Pharmaceuticals
PrivateLast Round
Series D
Nov 12, 2014
Total Funding Raised
$30.92M
Company Overview
Cantex Pharmaceuticals is a biotechnology company that develops biopharmaceutical technologies designed to improve the treatment of cancers and other life-threatening disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cantex Pharmaceuticals Comparables
Compare Cantex Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RAGE Biotech | 77% | |
| Arrowhead Pharmaceuticals | 69% | |
| RAPT Therapeutics | 66% | |
Cantex Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 12, 2014 | ||||
| Series C | Apr 11, 2014 | ||||
| Grant | Nov 3, 2010 | ||||
| Series B | Aug 25, 2006 | ||||
| Series A | Aug 12, 2002 |
Key People
Founding team and executive leadership
Cantex Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Research Corporation Technologies | Series B, Series C, Series A |
| Domain Associates | Series B, Series C, Series D |
| CHL Medical Partners | Series B, Series C |
| The Aurora Funds | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 31% MoM, reaching 1.9K.
- Apr 24, 2026
Monthly visitors increased 670% MoM.
Cantex Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cantex Pharmaceuticals's valuation, stock price, and market status.